We are live on
!
Find out more
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
41 hedge funds and large institutions have $81M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
13% less funds holding
Funds holding: 47 → 41 (-6)
33% less capital invested
Capital invested by funds: $120M → $81M (-$39.4M)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
41
Holders Change
-6
Holders Change %
-12.77%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
9
Closed
14
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$5.07M |
| 2 |
B
Bailard
Foster City,
California
|
+$1.68M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$290K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$276K |
| 5 |
Millennium Management
New York
|
+$249K |
